CompletedPhase 1NCT01188512

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

Studying Whooping cough

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Principal Investigator
Camille Locht, PhD
Institut National de la Santé Et de la Recherche Médicale, France
Intervention
BPZE1(biological)
Enrollment
48 enrolled
Eligibility
19-31 years · MALE
Timeline
2010 – 2012

Study locations (1)

Collaborators

European Union · Swedish Institute for Infectious Disease Control · Innogenetics

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01188512 on ClinicalTrials.gov

Other trials for Whooping cough

Additional recruiting or active studies for the same condition.

See all trials for Whooping cough →

← Back to all trials